April 27, 2018 | Blake Mossy
PRODUCT INTRODUCTION & UPDATE
Datum Biotech announced the founding of Datum Orthobiologics, a company focuses on creating advanced biomaterials for orthopedics basic on proven bone formation and tissue regeneration solutions. Its bio-programmable medical devices are designed to contribute to long-term healing and regeneration of musculoskeletal components. The company will focus on bone grafts for use in healing and spinal fusion.
DePuy Synthes launched its PROTI 360 Integrated Titanium Family of interbody devices for patients who have degenerative disc disease in the neck and back. The device is comprised of biocompatible material with mechanical properties that resemble human bone, and the implants are radiolucent, which aims to allow surgeons to easily assess the bone healing process over time.
Episurf Medical entered into a distribution agreement with Pacific Medical System in Hong Kong. Episurf has developed Episealer personalized implants and Epiguide drill guides to treat localized joint cartilage injury. Under the terms of the agreement, Pacific Medical Systems will be the distributor and Hong Kong will, as its first market in Asia where its technology will be marketed, also be a reference during its further expansion in the region.
Advanced Biomedical Technologies (ABT) received approval from the China Food and Drug Administration for its polymer orthopaedic internal fixation screws. The company intends to bring additional polyamide-based fixation products to the region, such as rib pins, binding wires, micromodule screws/plates and CMF plates. The products are indicated as an alternative to metal implants and other re-absorbable fixation devices, and are designed with the ability to control the speed by which the devices degrade.
Fidia Farmaceutici announced study results evaluating its HYMOVIS, an HA viscosupplement, effects on cartilage volume and type II collagen turnover in patients suffering from symptomatic knee osteoarthritis (OA). The study also demonstrates the potential beneficial effect of HYMOVIS on pain and function, suggesting that HYMOVIS could have a structural modifying effect in knee OA and provide critical information for the design of a larger clinical trial.
McGinley Orthopedics announced its milestone of 500 surgeries performed using the IntelliSense HandHeld Robotic Drill, designed to limit complications during routine orthopedic surgeries requiring screw and pin placement. The system utilizes integrated sensory technology that combines bone drilling and depth measurement into one process during surgery. It also uses auto-bone stop edge detection and direct lighting to illuminate the surgical field.